Dr. Elizabeth Garland is an Associate Professor in the Departments of Community and Preventive Medicine and Pediatrics at Mount Sinai School of Medicine. She has been the Chief of the Division of Preventive Medicine since May 2002 and the Director of the General Preventive Medicine Residency Program since 1995. She is a course director and the Specialty Track Coordinator for the Preventive Medicine Track of the MSSM M.P.H. Program. She has been the Director of the Student Health Center at Mount Sinai School of Medicine since 1997. She was the Co-Director of the third year Primary Care Clerkship from 1994 2002.
She received her bachelor's degree from Tufts University, her Medical Degree from Albany Medical College and her Masters of Science in Public Health and Nutrition from Columbia University. Both residencies in Pediatrics and Preventive Medicine were completed at The Mount Sinai Medical Center. She is a Fellow in the American College of Preventive Medicine and active on the GME Subcommittee and National Preventive Medicine Residency Directors Workshop committee. She recently reviewed the new Nutrition Counseling Recommendations for the United States Preventive Services Task Force.
Dr. Garland's has worked in the East Harlem community since 1981, and is the Co-Chair of the Pediatric/Child Health Sub-committee of the East Harlem Community Health Committee. Her research focused first on children's nutritional status, then on issues relating to pediatric immunization rates, immunization registry development and barriers to care. She has been clinically involved with socially high-risk families and evaluated pediatric home visiting interventions in East Harlem.
Public Health & General Preventive Medicine
Public Health [PH]
BS, Tufts University
MS, Columbia University
MD, Albany Medical College
Mount Sinai Hospital
Fellowship, Preventive Medicine
Mount Sinai Hospital
Dr. Garland's research interests have centered on health disparities: pediatric asthma, reducing risk factors for diabetes in adolescents and screening men for intimate partner violence. She is currently Principle Investigator of three grants: to develop and evaluate home-based remediation and education for children and families with asthma, violence prevention screening and education, and a grant from Pfizer to develop a Sexual and Reproductive Health Education curriculum at Mount Sinai School of Medicine. She is involved in research on student well-being, smoking cessation and needlestick prevention.
Foley ME, Garland E, Stimmel B, Merino R. Innovative Clinical Addiction Research Training Track in Preventive Medicine. Subst Abus 2000 Jun; 21(2): 111-119.
Bienenfeld L, Golden A, Garland E. Consumption of Fish From Polluted Waters by WIC Participants in East Harlem. J Urban Health 2003 June; 80(2): 349-358.
To minimize exposure to neurotoxins such as mercury, polychlorinated byphenyls (PCBs), dioxins, and pesticide residues, the New York State Department of Health issues health advisories about consumption of certain fish and shellfish caught from polluted local waters. Fetal exposure causes cognitive developmental deficits in children. Consumption of fish was assessed. We surveyed 220 WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) participants. Of the participants, 10% ate fish and shellfish caught in local polluted waters. Statistically significant factors associated with eating local, noncommercial fish included male gender and knowledge of the health advisory. Locally caught fish and crabs are consumed; thus, in utero and childhood exposure to these neurotoxins occurs. Interventions to promote safer choices of fish are needed.
Solomon A, Doucette J, Garland E, Mcginn T. Healthcare and the Long Haul: Long distance Truck Drivers, a Medically Underserved Population. Am J Ind Med 2004 Nov; 46(5): 463-71.
Krain A, Wisnivesky J, Garland E, Mcginn T. Prevalence of Human Immunodeficiency Virus Testing in Patients with Hepatitis B and C Infection. Mayo Clinic Proceedings 2004 Jan; 79(1): 51-6.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Garland did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.